Based on resonant acoustic profiling (Rap), Rapid4 enables real-time label-free measurement and analysis of biomolecular interactions with the highest level of accuracy reproducibility and sensitivity
Akubio, the acoustic biosensors company, launched its Rapid4 biomolecular interactions analysis system at the 12th Annual SBS conference and exhibition, Seattle, Washington.
Based on the company's pioneering resonant acoustic profiling (Rap) technology, Rapid4 enables real-time label-free measurement and analysis of biomolecular interactions with the highest level of accuracy, reproducibility and sensitivity.
Rapid4 is a flow-based system which reduces the need to purify samples and generates accurate kinetic, affinity and concentration measurements from complex mixtures, such as cell culture supernatants and periplasmic extracts.
A stand-alone, fully automated platform, Rapid4 requires minimal user intervention and is controlled via user-friendly software, typically processing an average of 400 samples per day.
Rap measures the oscillation of a resonating quartz crystal, which decreases in proportion to the mass of the molecules binding to its surface.
Researchers interrogate and evaluate the data using the intuitive Rapid Workbench software package.
Ian Campbell, business development director said: "Rapid4 allows users to work directly with complex samples, with minimal need for pre-assay purification or post-assay calibration.
"The system has been optimised for protein-protein interaction analysis and our application scientists continue to broaden the application areas of Rapid4".
Commenting on the launch, Andrew Mackintosh, CEO Akubio , said: "We are delighted to announce the launch of Rapid4, which represents an important step in the commercial development of Akubio and the delivery of an important new analytical tool to the pharmaceutical and general life science research community.
"While we are focussing on enabling the work of researchers, we believe that RAP will also have applications in broader markets.
"With our proprietary Rap acoustic technology, Akubio is set to become one of the world's leading biosensor companies."